Cargando…

Brucella – Virulence Factors, Pathogenesis and Treatment

Brucellae are Gram-negative, small rods infecting mammals and capable of causing disease called brucellosis. The infection results in abortion and sterility in domestic animals (sheeps, pigs, rams etc). Especially dangerous for humans are: Brucella melitensis, Brucella suis, Brucella abortus, and Br...

Descripción completa

Detalles Bibliográficos
Autores principales: GŁOWACKA, PATRYCJA, ŻAKOWSKA, DOROTA, NAYLOR, KATARZYNA, NIEMCEWICZ, MARCIN, BIELAWSKA-DRÓZD, AGATA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Exeley Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256693/
https://www.ncbi.nlm.nih.gov/pubmed/30015453
http://dx.doi.org/10.21307/pjm-2018-029
_version_ 1783539967616614400
author GŁOWACKA, PATRYCJA
ŻAKOWSKA, DOROTA
NAYLOR, KATARZYNA
NIEMCEWICZ, MARCIN
BIELAWSKA-DRÓZD, AGATA
author_facet GŁOWACKA, PATRYCJA
ŻAKOWSKA, DOROTA
NAYLOR, KATARZYNA
NIEMCEWICZ, MARCIN
BIELAWSKA-DRÓZD, AGATA
author_sort GŁOWACKA, PATRYCJA
collection PubMed
description Brucellae are Gram-negative, small rods infecting mammals and capable of causing disease called brucellosis. The infection results in abortion and sterility in domestic animals (sheeps, pigs, rams etc). Especially dangerous for humans are: Brucella melitensis, Brucella suis, Brucella abortus, and Brucella canis that trigger unspecific symptoms (flu-like manifestation). Brucella rods are introduced via host cells, by inhalation, skin abrasions, ingestion or mucosal membranes. The most important feature of Brucella is the ability to survive and multiply within both phagocytic and non-phagocytic cells. Brucella does not produce classical virulence factors: exotoxin, cytolisins, exoenzymes, plasmids, fimbria, and drug resistant forms. Major virulence factors are: lipopolysaccharide (LPS), T4SS secretion system and BvrR/BvrS system, which allow interaction with host cell surface, formation of an early, late BCV (Brucella Containing Vacuole) and interaction with endoplasmic reticulum (ER) when the bacteria multiply. The treatment of brucellosis is based on two-drug therapy, the most common combinations of antibiotics are: doxycycline with rifampicin or fluoroquinolones with rifampicin. Currently, also other methods are used to disrupt Brucella intracellular replication (tauroursodeoxycholic acid or ginseng saponin fraction A).
format Online
Article
Text
id pubmed-7256693
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Exeley Inc.
record_format MEDLINE/PubMed
spelling pubmed-72566932020-06-03 Brucella – Virulence Factors, Pathogenesis and Treatment GŁOWACKA, PATRYCJA ŻAKOWSKA, DOROTA NAYLOR, KATARZYNA NIEMCEWICZ, MARCIN BIELAWSKA-DRÓZD, AGATA Pol J Microbiol Microbiology Brucellae are Gram-negative, small rods infecting mammals and capable of causing disease called brucellosis. The infection results in abortion and sterility in domestic animals (sheeps, pigs, rams etc). Especially dangerous for humans are: Brucella melitensis, Brucella suis, Brucella abortus, and Brucella canis that trigger unspecific symptoms (flu-like manifestation). Brucella rods are introduced via host cells, by inhalation, skin abrasions, ingestion or mucosal membranes. The most important feature of Brucella is the ability to survive and multiply within both phagocytic and non-phagocytic cells. Brucella does not produce classical virulence factors: exotoxin, cytolisins, exoenzymes, plasmids, fimbria, and drug resistant forms. Major virulence factors are: lipopolysaccharide (LPS), T4SS secretion system and BvrR/BvrS system, which allow interaction with host cell surface, formation of an early, late BCV (Brucella Containing Vacuole) and interaction with endoplasmic reticulum (ER) when the bacteria multiply. The treatment of brucellosis is based on two-drug therapy, the most common combinations of antibiotics are: doxycycline with rifampicin or fluoroquinolones with rifampicin. Currently, also other methods are used to disrupt Brucella intracellular replication (tauroursodeoxycholic acid or ginseng saponin fraction A). Exeley Inc. 2018-06 2018-06-30 /pmc/articles/PMC7256693/ /pubmed/30015453 http://dx.doi.org/10.21307/pjm-2018-029 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Microbiology
GŁOWACKA, PATRYCJA
ŻAKOWSKA, DOROTA
NAYLOR, KATARZYNA
NIEMCEWICZ, MARCIN
BIELAWSKA-DRÓZD, AGATA
Brucella – Virulence Factors, Pathogenesis and Treatment
title Brucella – Virulence Factors, Pathogenesis and Treatment
title_full Brucella – Virulence Factors, Pathogenesis and Treatment
title_fullStr Brucella – Virulence Factors, Pathogenesis and Treatment
title_full_unstemmed Brucella – Virulence Factors, Pathogenesis and Treatment
title_short Brucella – Virulence Factors, Pathogenesis and Treatment
title_sort brucella – virulence factors, pathogenesis and treatment
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256693/
https://www.ncbi.nlm.nih.gov/pubmed/30015453
http://dx.doi.org/10.21307/pjm-2018-029
work_keys_str_mv AT głowackapatrycja brucellavirulencefactorspathogenesisandtreatment
AT zakowskadorota brucellavirulencefactorspathogenesisandtreatment
AT naylorkatarzyna brucellavirulencefactorspathogenesisandtreatment
AT niemcewiczmarcin brucellavirulencefactorspathogenesisandtreatment
AT bielawskadrozdagata brucellavirulencefactorspathogenesisandtreatment